Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)

Dan Li; Yanwei Shen; Hui Ren; Li Wang; Jin Yang; Yuan Wang

doi:10.1007/s10863-021-09896-2

Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)

Dan Li
, Yanwei Shen
, Hui Ren
, Li Wang
, Jin Yang
, Yuan Wang

The First Affiliated Hospital of Xi’an Jiaotong University

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

A Correction to this paper has been published: https://doi.org/10.1007/s10863-021-09896-2.

Original language	English
Pages (from-to)	307
Number of pages	1
Journal	Journal of Bioenergetics and Biomembranes
Volume	53
Issue number	3
DOIs	https://doi.org/10.1007/s10863-021-09896-2
State	Published - Jun 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s10863-021-09896-2

Fingerprint

Dive into the research topics of 'Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)'. Together they form a unique fingerprint.

Cite this

Li, D., Shen, Y., Ren, H., Wang, L., Yang, J., & Wang, Y. (2021). Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7). Journal of Bioenergetics and Biomembranes, 53(3), 307. https://doi.org/10.1007/s10863-021-09896-2

@article{668663cba45147d081b6356e924af60d,

title = "Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)",

abstract = "A Correction to this paper has been published: https://doi.org/10.1007/s10863-021-09896-2.",

author = "Dan Li and Yanwei Shen and Hui Ren and Li Wang and Jin Yang and Yuan Wang",

note = "Publisher Copyright: {\textcopyright} 2021, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2021",

month = jun,

doi = "10.1007/s10863-021-09896-2",

language = "英语",

volume = "53",

pages = "307",

journal = "Journal of Bioenergetics and Biomembranes",

issn = "0145-479X",

publisher = "Springer",

number = "3",

}

Li, D, Shen, Y, Ren, H, Wang, L, Yang, J & Wang, Y 2021, 'Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)', Journal of Bioenergetics and Biomembranes, vol. 53, no. 3, pp. 307. https://doi.org/10.1007/s10863-021-09896-2

Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7). / Li, Dan; Shen, Yanwei; Ren, Hui et al.
In: Journal of Bioenergetics and Biomembranes, Vol. 53, No. 3, 06.2021, p. 307.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)

AU - Li, Dan

AU - Shen, Yanwei

AU - Ren, Hui

AU - Wang, Li

AU - Yang, Jin

AU - Wang, Yuan

PY - 2021/6

Y1 - 2021/6

N2 - A Correction to this paper has been published: https://doi.org/10.1007/s10863-021-09896-2.

AB - A Correction to this paper has been published: https://doi.org/10.1007/s10863-021-09896-2.

UR - https://www.scopus.com/pages/publications/85105466106

U2 - 10.1007/s10863-021-09896-2

DO - 10.1007/s10863-021-09896-2

M3 - 评论/辩论

C2 - 33959833

AN - SCOPUS:85105466106

SN - 0145-479X

VL - 53

SP - 307

JO - Journal of Bioenergetics and Biomembranes

JF - Journal of Bioenergetics and Biomembranes

IS - 3

ER -

Li D, Shen Y, Ren H, Wang L, Yang J, Wang Y. Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7). Journal of Bioenergetics and Biomembranes. 2021 Jun;53(3):307. doi: 10.1007/s10863-021-09896-2

Correction to: Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway (Journal of Bioenergetics and Biomembranes, (2021), 53, 3, (295-305), 10.1007/s10863-021-09891-7)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this